Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users

Journal of Infectious Diseases

Volumn 178, Issue 2, 1998, Pages 388-396

  Yu, Xiao Fang ^a   Wang, Zhe ^a   Vlahov, David ^a   Markham, Richard B ^a   Farzadegan, Homayoon ^a   Margolick, Joseph B ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0031873026     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515646     Document Type: Article

References (25)

1. Alcabes P, Munoz A, Vlahov D, Friedland H. Incubation period of human immunodeficiency virus. Epidemiol Rev 1993;15:303-18.
2. Jason J, Liu KJ, Ragni M, Hessol N, Darrow W. Risk of developing AIDS in HIV-infected cohorts of hemophiliac and homosexual men. JAMA 1989;261:725-7.
3. Lifson AR, Rutherford GW, Jaffe HW. The natural history of human immunodeficiency virus infection. J Infect Dis 1988;158:1360-7.
4. Munoz A, Wang MC, Bass S, et al. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Am J Epidemiol 1989;130:530-9.
5. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow-up study. BMJ 1990;301:1183-8.
6. Buchbinder S, Katz M, Hessol N, O'Malley P, Holmberg S. Long-term HIV-1 infection without immunologic progression. AIDS 1994;8:1123-8.
7. Greenough TC, Somasuundaran M, Brettler DB, et al. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1994;10:395-403.
8. + cell counts. J Infect Dis 1994;169:1236-43.
9. Schrager L, Young J, Fowler MG, Mathieson B, Vermund S. Long-term survivors of HIV-1 infection: definitions and research challenges. AIDS 1994;8(suppl 1):S95-I08.
10. + T-cell levels. AIDS 1993;7:1159-66.
11. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med 1992;326:1385-91.
12. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
13. Patterson BK, Till M, Otto P, et al. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 1993;260:976-9.
14. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
15. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
16. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-62.
17. Pantaleo G, Grazios C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
18. Asjo B, Albert J, Karlsson A, et al. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986;2:660-2.
19. Cheng-Mayer C, Seto D, Tateno M, Levy J. Biologic features of HIV-1 that correlate with virulence in the host. Science 1988;240:80-2.
20. +-lymphocyte decline and clinical progression in human immunodeficiency virus type-1 infected individuals. J Virol 1993;67:1772-7.
21. Connor R, Ho DD. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 1994;68:4400-8.
22. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
23. Kuiken C, Jong J, Baan E, Keulen W, Tersmette M, Goudsmit J. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J Virol 1992;66:4622-7.
24. Richman D, Bozzette S. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994;169:968-74.
25. + lymphocytes. Proc Natl Acad Sci USA 1994;91:1104-8.